Home » Cancer-Vaccine Report Boosts Dendreon Stock
Cancer-Vaccine Report Boosts Dendreon Stock
Dendreon shares rose sharply Tuesday as a scientific article cast a positive light on therapeutic cancer vaccines, a family of newly bioengineered products that includes the company’s flagship prostate-cancer treatment, Provenge.
The Seattle Times
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May